A Study Of Poly (ADP-Ribose) Polymerase Inhibitor PF-01367338 In Combination With Several Chemotherapeutic Regimens

NCT01009190 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: PF-01367338
DRUG: Carboplatin
DRUG: PF-01367338
DRUG: Carboplatin

Sponsor

pharmaand GmbH